Covid Nasal medicine will be available from January

Patna(Imam Ali/Insaaf Times) Indian company Bharat Biotech said that the COVID nasal drug ‘Incovac (BBV 154)’ for the covid epidemic will be available at the market and government level from the fourth week of January next year.The company has said that it will be available through the Covin portal.

All adults receiving the covid vaccine and covid shield will be able to receive it as a third or booster dose. Private hospitals will get this medicine at Rs 800 per dose and the government will get Rs 325 per dose.In a statement issued in Hyderabad on Monday, the company said that Incovac has also received approval as the first two doses for protection against Covid.

Bharat Biotech said that Incovac has received approval from the Central Drug Standard Control Organization (CDSCO). This medicine will be given to the patient through the nose. This drug is specially designed for citizens of low and middle-income citizens.

Relief Amid LPG Shortage: Government to Provide Kerosene as Alternative Fuel Across 21 States and UTs

Amid continuous supply disruptions and rising prices of cooking gas (LPG) across the country, the

Defense to Global Force: A Roadmap of U.S.–India Partnership in the 21st Century — Conversation with US Ambassador Sergio Gor

The U.S. Ambassador Sergio Gor explains how to shape U.S.–India relations as a defining strategic

Gulf Conflict: Turkey Blocks Israel‑U.S. Plan, Kurdish Proxy Force in Iran Foiled, Civil War Threat Averted

Turkey’s firm warning and active diplomacy have successfully thwarted a plan by Israel and the

Bihar Board Class 10 Result 2026: Girls Dominate, Pushpanjali and Sabrin Create History

The wait has finally ended for lakhs of students in Bihar, as the Bihar School